CD8A and nonpapillary renal cell carcinoma: Our research not merely identifies the critical anti-tumor mechanisms of CD45RO+/CD8+ T lymphocytes in ccRCC, yet also establishes a non-invasive diagnostic method of potentiality and therapeutic tactics for patients bearing ccRCC.